CYduct Diagnostics Inc (CYDX)

[lchase01]

Summary of President's Letter:

1. Stage 1 Audit with TUV SUD America was completed on 2/26/13.

2. Stage 2 Audit for ISO 13485 is scheduled 8/16/13; once completed and CE certification obtained, MammoView devices will be able to be sold in Canada and EU.

3. Solos Endoscopy has retained Emergo Group as authorized representative in Europe.

4. Core business is development and marketing of medical technology, applications, medical devices and procedural techniques.

5. Assets decreased, but so did liabilities.

6. Positive Net Book Value.

7. Increase of sales from same period last year.

8. Increase in revenues.

9. Expenses decreased as did Net Loss.

10. Stock was issued to CEO, not cash, for salary.